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Abstract: The development of a modified DNA aptamer that binds HIV-1 reverse transcriptase
(RT) with ultra-high affinity has enabled the X-ray structure determination of an HIV-1 RT-DNA
complex to 2.3 A˚ resolution without the need for an antibody Fab fragment or RT-DNA cross-
linking. The 38-mer hairpin-DNA aptamer has a 15 base-pair duplex, a three-deoxythymidine hair-
pin loop, and a five-nucleotide 50-overhang. The aptamer binds RT in a template-primer configu-
ration with the 30-end positioned at the polymerase active site and has 20-O-methyl modifications
at the second and fourth duplex template nucleotides that interact with the p66 fingers and
palm subdomains. This structure represents the highest resolution RT-nucleic acid structure to
date. The RT-aptamer complex is catalytically active and can serve as a platform for studying
fundamental RT mechanisms and for development of anti-HIV inhibitors through fragment
screening and other approaches. Additionally, the structure allows for a detailed look at a
unique aptamer design and provides the molecular basis for its remarkably high affinity for RT.
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Introduction
HIV-1 reverse transcriptase (RT) is an essential
enzyme in the retroviral life cycle. RT converts the
single-stranded viral RNA genome into double-
stranded DNA via its RNA- and DNA-dependent
DNA polymerase and RNase H activities.1–3 The
multifunctional nature of RT requires that it
bind both RNA/DNA and DNA/DNA (dsDNA)
substrates.
The first structure of an RT/dsDNA complex
was determined in the presence of an antibody Fab
fragment.4 This “binary” structure defined the
nucleic acid binding track extending from the poly-
merase to the RNase H active sites and also defined
structural elements involved in template-primer
binding, including the “primer grip” and “template
grip.” A cross-linking strategy using disulfide tether-
ing was later used to generate a new RT/DNA crys-
tal form that could accommodate an incoming dNTP
in an RT/DNA/dNTP ternary precatalytic complex.5
Subsequently, both cross-linking and Fab were used
to study the structural basis of RNA/DNA binding
and RNA degradation, the resilience of the polypur-
ine tract (PPT) to degradation, the catalytic
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incorporation of nucleotides and nucleoside analog
drugs (NRTIs), and the molecular mechanisms of
resistance to NRTIs by different RT mutations (for
reviews see Refs. 3, 6). The cross-linking and Fab
approaches require specialized reagents and addi-
tional purification steps that can hamper efficient
application of currently available RT/nucleic acid
complexes to structure-based drug design efforts.
Structure-based drug design with RT has been
successful in the development of two non-nucleoside
RT drugs: etravirine/Intelence and rilpivirine/Edur-
ant.6,7 A protein engineering effort8 from our group
generated robust crystals of RT that diffract to high
resolution and enabled a crystallographic fragment-
screening campaign to find new allosteric inhibitory
binding sites in RT.9 Analogous drug design and
fragment screening with RT/DNA complexes will
require highly reproducible and well diffracting
crystals.
DNA aptamers with tight binding affinities for
their target proteins that contain modified nucleo-
tides have been developed by exploiting the higher
structural diversity of these modifications.10 While
aptamers typically have complex three-dimensional
structures with novel base-pairing interactions, they
can also be created with simpler topologies and still
retain the signature characteristics of aptamers: the
ability to bind proteins with a high degree of speci-
ficity and affinity. Previous selective evolution of
ligands by exponential enrichment (SELEX) studies
have demonstrated that aptamers can inhibit HIV
replication through specific high affinity interactions
with RT.11–15 Application of a modified SELEX
approach has led to the development of a nucleic
acid template–primer aptamer that binds RT with
significantly higher affinity than a typical unse-
lected template–primer substrate.16 These newly
designed aptamers have helped explain RT’s higher
affinity to RNA/DNA vs. dsDNA templates by show-
ing that even a single RNA nucleotide in the tem-
plate strand near the polymerase active site can
significantly increase binding affinity. The use of the
more chemically stable 20-O-methylation to mimic
the RNA 20-hydroxyl retained higher binding
affinity.16
The structure of a tight-binding 38-mer DNA
aptamer complex with RT has been solved to 2.3 A˚
resolution, the highest resolution for an RT/nucleic
acid complex so far. This crystal form should facili-
tate efficient fragment screening and structure-
based drug design regimes for HIV-1 RT complexed
with nucleic acid and may enable the development
of novel inhibitors that bind only in the presence of
nucleic acid. In addition, the structure and associ-
ated technological platform could enhance our
understanding of fundamental RT polymerization
mechanisms.
Results
Construction and biochemical analysis of the
38-mer DNA aptamer (with 20-O-methyl
modifications at the second and fourth duplex
template positions)
The aptamer used for crystallization was originally
derived from selection for tight binding to HIV-1 RT of
nucleic acid duplexes in a template-primer configura-
tion, using a modified SELEX (Selective Evolution of
Ligands by Exponential Enrichment) approach.17 The
selected duplexes resembled the polypurine tract
(PPT) sequence of HIV in that they had an extended
run of deoxyguanosines at the 30 end. These duplexes
were further modified to produce “38NT SELEX,” a 38
nucleotide single-stranded loop-back aptamer with
seven 30 deoxyguanosines and a five base 50 over-
hang.18 Aptamer 38NT2,4-methyl was made from
38NT SELEX by replacing the deoxycytosine residues
that were hybridized to the deoxyguanosines in the
22 and 24 (relative to the 30 terminus) positions with
20-O-methylcytosine. This modification was based on
previous results showing that replacing nucleotides at
these positions in the template strand of DNA–DNA
template–primers with either rNTPs or 20-O-methyl
modified nucleotides resulted in high affinity binding
with RT.16 Consistent with this, 38NT SELEX bound
to HIV-1 RT with a KD of 1636 24 pM and the complex
has a half-life of 476 4 min. For comparison, unse-
lected dsDNA with the same configuration bind to RT
with 100 nM affinity.18 Further, 38NT2,4-methyl
DNA showed an 10-fold increase in binding affinity
over 38NT SELEX with a KD of 13.76 1.8 pM and the
half-life of 1266 54 min (Supporting Information
Table I).
Structure of RT-aptamer complex
The RT-aptamer structure was solved and refined to
2.3 A˚ resolution. This binary complex consists of a
p66/p51 heterodimer bound to the 38-mer DNA
aptamer; the protein architecture is dominated by a
large nucleic acid binding track running along the
length of the heterodimer (Fig. 1). The complex crys-
tallized in a condition and crystal form similar to
those obtained earlier for RT/dsDNA and RT/RNA/
DNA crosslinked complexes (Table I).23,24 The crystal
asymmetric unit contains two copies of RT/aptamer
complex. Electron density is not seen for residues
beyond 544 of p66 in one heterodimer and 553 in the
second copy. The heterodimers in the asymmetric unit
superimpose with an RMSD of 1.34 A˚ for protein Ca
atoms and 0.55 A˚ for nucleic acid atoms. The greatest
variation between the two copies in the asymmetric
unit occurs among RT residues 29–45 of the fingers
and the RNase H domains.
The aptamer has clear electron density for 35
of the 38 nucleotides [Supporting Information
Fig. 3(A,B)]; three single-stranded nucleotides at the
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50-end are disordered. Numbering of the nucleotides in
the aptamer (from the 50 end) begins with 24 to 0 for
the template overhang, 1–15 for the template duplex
strand, 16–18 for the hairpin loop, and 19–33 for the
primer duplex strand [Fig. 2(A)]. All of the 30 comple-
mentary residues in the duplex region (Supporting
Information Fig. 1) form Watson–Crick base pairs. The
second and fourth template nucleotides of the aptamer,
referenced from the first base-paired nucleotide resi-
dues at the primer terminus, contain the 20-O-methyl
modifications, which are well resolved in the electron
density map [Supporting Information Fig. 3(C,D)] and
are positioned near the base of the fingers and palm
subdomains. Conformational analysis of the aptamer
using the program x3DNA25 indicates that the first five
base pairs of the duplex adopt an A-like conformation
and the remaining nucleotide base pairs conform to B-
form geometry [Fig. 2(A)], which is consistent with the
conformation of normal dsDNA template–primers
bound to RT.4
Three deoxythymidines (nucleotides 16–18) form
the hairpin loop and are bound near the RNase H
primer grip.26 The nucleotide bases of the three
deoxythymidines are ordered in the structure and
form non-Watson–Crick hydrogen bonds to the DNA
[Fig. 5(A,B)].
The B-factors of the crosslinked dsDNA
(3V6D)23 range from 47 to 179. The B-factors of the
aptamer range from 43 to 178 (Supporting Informa-
tion Fig. 2) with the lowest B-factors near the poly-
merase and RNase H active sites, reflecting that the
DNA aptamer is most ordered in the regions with
the most extensive contacts with RT. The aptamer
structure B-factors were refined using a translation/
libration/screw motion determination (TLSMD)
model, which allows for anisotropic B-factor refine-
ment at lower than atomic resolution. As a result of
this refinement the isotropic B-factors increase,
which explains the apparent similarity in B-factor
range between the two structures.
DNA conformation and protein–DNA
interactions
The network of interactions between RT and the
aptamer is shown in Figure 2(A), and the interact-
ing surface area for individual nucleotides is shown
in Figure 2(B). The distances are listed in Support-
ing Information Table I. With the exception of the
electrostatic interactions between Gly152 to C1 and
Tyr183 to C3, all of the interactions are between the
protein and sugar-phosphate backbone of the
aptamer. There is one water-mediated interaction
between Glu478 and T17. There are 30 residues of
p66 that interact with aptamer nucleotides through
side-chain contacts. They are clustered in three
groups: dsDNA interacting with the polymerase
domain (nucleotides 0–8 and 28–33) where the ter-
minus of the aptamer interacts with key amino acid
residues in the p66 fingers, palm, and thumb subdo-
mains; the hairpin loop (nucleotides 16–18); and the
remaining dsDNA near the RNase H domain (nucle-
otides 18–23). There is only one direct protein–DNA
interaction with the three deoxythymidine residues
that make up the hairpin loop, a hydrogen bond
between Asn474 and the phosphate of T18 [Fig.
4(C)]. The solvent-accessible surface area for each
Figure 1. Overview of HIV-1 RT/aptamer complex. A. HIV-1 RT p66/p51 heterodimer (gray) shown with DNA aptamer colored
in green. The first duplex DNA base pair is located at the polymerase active site and the aptamer hairpin residues are located
near the RNase H active site. B. Representative electron density for the aptamer shown centered on the polymerase active site
region.
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nucleotide buried in the context of RT is shown in
Figure 2(B).
Interactions of 20-O-methyl groups
The 20-O-methylcytidine residues at positions two and
four in the duplex template strand of the aptamer
experience different electrostatic environments
[Fig. 3(A)]. The first 20-O-methyl sits in a negatively
charged environment dominated by Glu89 and
Gln161 as well as the more distant Met184. The 20-O-
methyl at position four, however, occupies a rather
hydrophobic pocket with no side chains or main-chain
carbonyl atoms within hydrogen-bonding distance of
the 20-O-methyl oxygen. The nearest side chain to the
20-O-methyl at position four is that of the hydrophobic
residue Ile94. Separating the two 20-O-methyl modi-
fied nucleotides is a loop in RT comprised of residues
91–95 of p66 with Glu91 situated beneath the third
aptamer nucleotide. In addition, there is a hydrogen
bond between the third aptamer residue (C3) and the
phenoxyl oxygen of Tyr183.
The oxygen of the 20-O-methyl in the second duplex
template position forms an electrostatic interaction
with RT via the side chain of Glu89 with a distance of
3.1 A˚ [Fig. 3(B)]; the carboxylate of the Glu89 side
chain also interacts with water that forms a bridging
interaction to the amide oxygen of the Gln161 side
chain. The 20-O-methyl modification in the fourth
position lacks direct protein interactions [Fig. 3(C)],
but there is a water molecule bridging from the 20-O-
methyl oxygen to the peptide backbone nitrogen
of Ile94.
Structural comparison of RT-aptamer to RT
cross-linked to dsDNA
The overall fold of RT in the RT/aptamer complex is
similar to structures of RT bound to cross-linked dsDNA
(RMSD of 0.54 A˚ to 3V6D). The path of the crosslinked
dsDNA through the RT binding cleft is similar to that of
the aptamer [Fig. 4(A)] and shows similar interactions
(Supporting Information Table I). The aptamer DNA
and crosslinked dsDNA structures have similar confor-
mations near the polymerase active site but diverge
toward the RNase H active site [Fig. 4(A,B)]. A compari-
son of the averaged DNA base-pairing parameters of
the aptamer to the crosslinked DNA shows that they
are similar by most metrics (Supporting Information
Table III). Comparing the active site residues of the
aptamer and crosslinked structures shows that the cat-
alytic residues D110, D185, and D186 are superimpos-
able [Supporting Information Fig. 4(A)]. In the region of
the crosslinked structure where the protein is linked via
a disulfide tethering to the DNA (at residue Q258C to
the sixth base of the primer strand) there is no signifi-
cant displacement [Supporting Information Fig. 4(B)].
While the minor groove distances are nearly identical to
those of the crosslinked structure near the polymerase
active site, one consequence of the hairpin is a compres-
sion of the minor groove (by >2 A˚ for the 10th and 11th
duplex positions) near the RNase H domain (Supporting
Information Fig. 5). The minor groove is 1 A˚ narrower
in the aptamer DNA vs. crosslinked DNA in the vicinity
of the p66 thumb subdomain.
Location and interactions of the hairpin with the
RNase H domain
The polymerase and RNase H active sites of RT are sep-
arated by 18 duplex base pairs.4 The 15 base-pair
aptamer duplex spans the polymerase active site to
within 9 A˚ of the RNase H active site [Fig. 4(A)]. Unlike
conventional dsDNA template-primers, the aptamer
loops back to form the template strand [Fig. 4(C)]. The
3-dT hairpin loop (nucleotides 16–18) interacts primar-
ily with the RNase H primer grip. The aptamer hairpin
loop makes a unique set of interactions with RT that
likely facilitates the tight binding measured between
RT and the aptamer. There are hydrogen bonds
between the protein and the aptamer from Gln475 to
the ribose of G19, Asn474 to the phosphate of T19,
Tyr501 to the phosphate of A21 and the O2 of C20, and
Thr473 to the phosphate of G19 [Fig. 4(C)]. There is
Table I. Data Processing and Refinement Statistics
Calculated Using HKL200019 and PHENIX,20–22
Respectively
PDB ID 5D3G
Wavelength (A˚) 0.9179
Resolution range (A˚) 30.00–2.30 (2.34–2.30)
Space group P21
Unit cell (A˚ and 8) 90.02 128.91 132.62
90.0 101.3 90.0
Total reflections 886,233 (97,902)
Unique reflections 133,446 (6,567)
Redundancy 6.6 (5.5)
Completeness (%) 99.3 (98.5)
Mean I/sigma (I) 17.1 (2.0)
Wilson B-factor (A˚2) 43.5
Rmerge 0.09 (0.76)
Rmeas 0.11 (0.97)
Rpim 0.04 (0.39)
Rwork 0.191 (0.321)
Rfree 0.225 (0.322)
Number of atoms
All 17,868
Protein 15,857
DNA 1,442
Glycerol/sucrose/sulfate 122
Water 447
RMS bonds (A˚) 0.004
RMS angles (8) 0.920
Ramachandran favored (%) 97.8
Ramachandran allowed (%) 2.2
Ramachandran outliers (%) 0
Clashscore 1.83
Average B-factors (A˚2)
All atoms 73.9
Protein 73.8
DNA 81.7
Glycerol/sucrose/sulfate 72.0
Water 54.7
Data for highest resolution range shell are shown in
parentheses.
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also a water molecule bridging Glu478 to the phosphate
of T17. The aptamer makes a series of intramolecular
interactions, which presumably would increase the sta-
bility in a manner that is consistent with what has
been determined by biophysical analysis of DNA.27,28
Adjacent to the aptamer hairpin G19 makes Watson–
Crick hydrogen bonds to C15. C15 is involved in a base-
stacking interaction with T17 of the hairpin loop [Fig.
5(A)]. Residue T16 is flipped internally to the loop and
makes hydrogen bonds with the base and ribose moi-
eties of C20 and A21 [Fig. 5(B)].
Discussion
Rationale for aptamer affinity
The direct visualization of a high-affinity aptamer
bound to RT illustrates that the key features of the
aptamer are the 20-O-methyl base modifications at
positions two and four and the inclusion of a short
hairpin loop composed of a triplet of deoxythymidine
residues. In addition, the structure also serves to fur-
ther validate the findings from structures of RT cross-
linked to DNA, since there appears to be very little
distortion of the DNA backbone as a result of the cova-
lent tether linking RT to DNA. The aptamer with 20-
O-methyl modifications contains two features that
may explain the 10-fold increase in affinity as com-
pared to the aptamer without 20-O-methyl modifica-
tions. One feature is an interaction between Glu89
and the first 20-O-methyl group on the second duplex
template nucleotide that likely recapitulates a similar
interaction with an RNA 20-OH. Another feature is
that the second 20-O-methyl group (at duplex template
position four) does not make protein–nucleic acid
Figure 2. Aptamer Interactions. A. Diagram showing the protein-aptamer interactions that are within hydrogen-bonding dis-
tance. The first three residues are shown in gray to indicate that they are disordered in the structure. The 20-O-methyl modified
nucleotides are indicated in red. B. Buried surface area of each nucleotide of the aptamer shown as a bar graph.
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contacts, but does occupy a pocket [Fig. 3(A)] and has
a water-mediated interaction between the 20-O-
methyl oxygen and the peptide backbone nitrogen of
Ile94 [Fig. 3(C)].
The role of the hairpin in stabilizing the
aptamer is twofold. There is a series of hydrogen
bonds between the DNA backbone and RT, but these
are comparable to interactions seen in the cross-
linked dsDNA structure5 as well as in non-
crosslinked dsDNA and RNA/DNA structures (Sup-
porting Information Table II).4,26 Additional
enhancement of the aptamer stability is improved
by the interactions of the hairpin with RT. Previous
work has shown that hairpin loops that are small
and stabilized by charged ions, or in this case by
charged side chains, had an increase in their Tm as
the number of nucleotides in the hairpin loops
decreased.27 The maximum stability, as indicated by
Tm, was found when DNA loops were composed of
deoxythymidine residues with lengths of three to
five bases. This is consistent with the composition of
the aptamer in this study.28
The SELEX experiments revealed that a string
of seven deoxycytidine residues in the template
strand led to the highest binding affinity,18 presum-
ably by forming a highly stable G:C duplex. The role
of the purine-rich region of the aptamer may con-
tribute to its high affinity by preferentially adopting
an A-like conformation. The conformation of dsDNA
at the RT polymerase active site is A-like and transi-
tions to B-form toward the RNase H site in all
RT/dsDNA structures. Duplex DNA with a more
random base distribution may favor B-form in solu-
tion and adopt an A-like conformation once bound
to RT. Dickerson et al. have shown that G-C-rich
stretches of six or more residues adopt an A-like
DNA conformation.29 We propose that the G-C-rich
region of the aptamer is preformed as A-like and
represents a ground-state form of the RT-bound
DNA. Polypurine DNA may have biological rele-
vance since the HIV genome contains stretches of
polypurine nucleotides that play a critical role in
reverse transcription.26,30
Finally, this structure offers a new framework
for studying RT-DNA complexes at higher resolution
than previously available and may enable systematic
approaches such as crystallographic fragment
screening for identification of new small molecule
classes as potential inhibitors or chemical probes of
RT function.
Figure 3. Interactions between aptamer and RT. A. RT molecular surface colored by electrostatic potential with the aptamer
(colored by atom type) overlaid. The asterisks denote the locations of 20-O-methyls. B. Residue two 20-O-methyl shown with short
electrostatic contact with Glu89. C. Residue four 20-O-methyl shown in neutral pocket with water mediated interaction to Ile94.
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Materials and Methods
Aptamer design and selection: End-labeling of
38NT2,4-methyl aptamer with T4 polynucleotide
kinase (PNK)
Aptamers (synthesized without 50 phosphate) were
50 32P end-labeled in a 50-mL volume containing
10 pmole of aptamer, 1X T4 polynucleotide kinase
reaction buffer (New England Biolabs), 10 U of T4 PNK
enzyme, and 10 mL of (g-32P) ATP (3000 Ci mmol21,
10 mCi mL21). The labeling reaction was done at 378C
for 30 min according to manufacturer’s protocol. PNK
enzyme was heat-inactivated by incubating the reac-
tion at 758C for 15 min. Excess radiolabeled nucleotides
were removed by centrifugation using a Sephadex G-25
column (Harvard Apparatus).
Dissociation rate constant (KD) and half-life (t1/2)
determinations using nitrocellulose filter binding
assay
Reactions for KD determinations were performed in
1 mL of buffer containing (final concentrations): 2
pM 50 end-labeled aptamer, 50 mM Tris-HCl pH 8,
Figure 4. Comparison of the RT/aptamer structure (green) with the RT/cross-linked-dsDNA structure (3V6D) (blue). A. Nucleic
acid binding cleft with the polymerase active site at the left and RNase H active site on the right. B. Aptamer hairpin (green)
and cross-linked-dsDNA template strand (blue). Cross-linked-dsDNA template strand shown extending into RNase H active
site. C. Aptamer binding pocket shown with selected side chains that are within 3.8 A˚ of nucleic acid atoms. A water molecule,
shown as a red sphere, forms hydrogen bonds with Glu478 and the phosphate of T17.
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80 mM KCl, 1 mM DTT, 2 mM MgCl2, and 0.1
mg mL21 BSA. Increasing amounts of HIV-1 RT (pre-
pared as described in Hou et al.31) diluted in the
above reaction buffer were added at the following
final concentrations for analysis of 38NT2, 4-methyl
DNA: 0, 1 pM, 2 pM, 4 pM, 8 pM, 16 pM, 32 pM, 64
pM, 128 pM, 256 pM, and 10 nM; and for 38NT
SELEX: 0, 12.5 pM, 25 pM, 50 pM, 100 pM, 150 pM,
200 pM, 250 pM, 400 pM, 800 pM, 1.6 nM, and 10
nM. After 10 min at room temperature, the reactions
were applied to a 25-mm nitrocellulose disk (0.45-
mm pore, Protran BA 85, WhatmanTM) presoaked in
filter wash buffer (25 mM Tris-HCl pH 7.5, 10 mM
KCl) under vacuum. The filter was washed three
times with 1 mL of wash buffer at a flow rate of
0.5 mL sec21. Filters were then counted in a scin-
tillation counter. The concentration of bound
aptamer was determined for each RT concentration
using the 10 nM saturating RT level as a reference
for the maximum amount of material that could be
bound in the assay. A plot of bound aptamer vs. RT
concentration was fit to the following equation using
KaleidaGraph in order to determine the KD:
[ED]50.5([E]t1 [D]t1KD) – 0.5(([E]t1 [D]t1KD)
2 –
4[E]t[D]t)1/2, where [E]t is the total enzyme concen-
tration and [D]t is the total primer–template concen-
tration.32 Half-life determinations were performed in
the same buffer with 5 nM (final concentration) of 50
end-labeled aptamer and 5 nM of HIV RT in 98 mL.
The reaction was incubated at room temperature for
5 min. Two microliters of nonradioactive aptamer
(1 mM final concentration) was added to the reaction
at time “0.” This was used as a “trap” to sequester
RT molecules as they dissociated from the labeled
aptamer. Aliquots of 10 mL were vacuum filtered as
above at times 0 min, 15 min, 30 min, 60 min, 90
min, 120 min, 180 min, and 240 min. The nitrocellu-
lose filter disks were washed and processed as
described above. Off-rates (koff) were determined by
plotting the retained counts vs. time, and fitting the
data to an equation for single, two parameter expo-
nential decay using SigmaPlot. Half-life values were
calculated from koff using the equation t1/25 0.693/
koff. Experiments were repeated at least three times
and averages6 standard deviations are reported.
RT expression and purification
HIV-1 RT plasmid RT152A allows for the co-
expression of p66D555 and p51D428. The RT152A
construct produces protein mutations in p66:C280S,
D498N; and in p51: C280S. The protein was cloned,
expressed, and purified following the previously pub-
lished protocol.8 The 38-nucleotide DNA aptamer,
38NT2,4-methyl, (Supporting Information Fig. 1)
with 20-O-methyl at the second and fourth duplex
positions of the template strand, was custom synthe-
sized by Integrated DNA Technologies and Midland
Certified Reagent Company. The complex of RT and
aptamer was generated by mixing RT at a concen-
tration of 85 mM (10 mg mL21) with a 1.2-fold excess
of 38NT2,4-methyl. Gel filtration analysis indicated
a single peak corresponding to a 1:1 RT/aptamer
complex in addition to a small amount of unbound
DNA (data not shown).
Crystallization
The RT/38NT2,4-methyl DNA complex was subjected
to crystallization condition screening using Hampton
Figure 5. Aptamer hydrogen-bonding interactions. Template strand is shown in blue, primer strand is shown in green, and
hairpin-loop residues in red. A. View of the aptamer looking towards the RNase H active site with bonding network created by
T16, T17, and G19. B. 1808 Rotation of A, showing interactions of T16.
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Research Index Screen HT and Crystal Screen HT,
and Rigaku Wizard Classic Screens I and II. Drops
with a final volume of 0.4 mL were setup in a 1:1
ratio of well solution to protein complex solution in
96 well Intelli-Plates using an Art Robbins Instru-
ments Gryphon Crystallization Robot. The plates
were incubated at 48C and were monitored for crys-
tal growth. The final crystals used for diffraction
experiments were crystallized using the hanging
drop method utilizing conditions previously identi-
fied.24 The well solution was composed of 7–10%
(w/v) PEG 8000, 25 mM Bis-tris Propane pH
6.8, 75 mM Bis-tris Propane pH 7.4, 50 mM ammo-
nium sulfate, 5% (v/v) glycerol, and 5% (w/v) sucrose.
A 1:1 ratio of protein-to-well solution was suspended
in a 2 mL drop over a 1-mL well. Plates were incu-
bated for 7–14 days at 48C.
Crystals were prepared for flash cooling in liquid
nitrogen by transferring them step-wise into solutions
containing the crystallization buffers supplemented
with increasing amounts of glycerol until the final
concentration was 25% (v/v).
Data collection, processing, and structure
determination
Data were collected on flash-cooled crystals at 100 K on
the F1 beamline at the Cornell High Energy
Synchrotron Source. A 3608 dataset was collected on an
ADSC Q270 at a wavelength of 0.9179 A˚ with 18 oscilla-
tions. The data were integrated and scaled using
HKL2000.19 Phasing was performed by molecular
replacement using phenix.phaser20,21 with the PDB
entry 3DLK and refinement was completed with
phenix.refine. 21,22,33 There were two complexes in the
asymmetric unit, therefore non-crystallographic symme-
try (NCS) restraints were used between the two copies
of p66, p51, and aptamer. A combination of NCS
restraints and TLS refinement produced a final model
with significantly improved agreement indices and ster-
eochemical quality vs. other strategies of refinement.
Inclusion of TLS parameterization led to a lowering of
Rfree from 0.24 to 0.225, but also led to a substantial
increase of the average underlying isotropic B factors
(74 A˚2 vs. 69 A˚2). Manual rebuilding was performed
using Coot.34 Data and refinement statistics are shown
in Table I. Figures were generated using PyMol.35 Struc-
ture analysis was performed using x3DNA,25 PyMol,35
cealign,36 and NCONT.37 The coordinates were depos-
ited in the PDB under accession number 5D3G.
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